Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New German bill to end pharmaceutical price "manipulation" in Germany

This article was originally published in Scrip

Executive Summary

The German authorities will seek compensation from pharmaceutical companies that "manipulated" their medicine prices in order to try to offset the discounts that they were obliged to offer to health insurers. The provision is part of Germany's new bill on the Reorganization of the Pharmaceutical Market (Arzneimittelmarkt-Neuordnungsgesetz; Amnog)which was last week finalised by the parliament and which will come into effect in January 2011.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts